The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
A single-arm, open-label study to evaluate the efficacy and safety of Acetylcysteine plus
high-dose Dexamethasone in adults newly diagnosed with primary immune thrombocytopenia (ITP).